Biotech Nektar Therapeutics to Participate in Two Investor Conferences in September September 5, 2025
Biotech Dr. Sunil Chandran Rejoins Amyris as Chief Technology Officer to Meet Growing Customer Demand for Innovative and Renewable Biological Chemistry September 4, 2025
Biotech Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting September 3, 2025
Biotech CMEF 2025: Promoting Holistic and High-Quality Development of Medical and Health Industry September 2, 2025
Biotech US FDA approves Leqembi® IQKLIK ™ (lecanemab-irmb) subcutaneous injection for maintenance dosing for the treatment of early Alzheimer’s disease September 1, 2025
Biotech UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress August 30, 2025
Biotech Resolution Therapeutics to host virtual R&D webinar alongside world leading clinical hepatologists Prof. Jonathan Fallowfield and Dr. Elliot Tapper August 28, 2025
Biotech BioArctic and Novartis sign an option, collaboration and license agreement using BrainTransporter™ for an upfront payment of USD 30 million plus additional potential milestones and royalties August 27, 2025